NEWTOWN, Pa.--(BUSINESS WIRE)--CollaGenex Pharmaceuticals, Inc. (NASDAQ:CGPI) today announced that it had signed a loan modification agreement with SVB Silicon Valley Bank (SVB) to expand its line of credit from $5 million to $10 million. The line of credit will be available to fund the Company’s working capital needs.
